How Does Apomorphine Work? Mechanism of Action Explained in Plain English

Apomorphine is one of the most unique medications in neurology. It works differently from most Parkinson's drugs—not by boosting dopamine levels in the brain, but by directly impersonating dopamine. This guide explains how that works, why it makes apomorphine so effective as a rescue medication, and why it also causes some of its most notable side effects.

First: What Is Dopamine and Why Does Parkinson's Affect It?

Dopamine is a chemical messenger (neurotransmitter) in the brain that plays a key role in controlling movement. In a healthy brain, a region called the substantia nigra produces dopamine and releases it into a nearby area called the striatum (which includes the caudate and putamen). This dopamine signal is what allows smooth, coordinated movements.

In Parkinson's disease, the neurons in the substantia nigra progressively die. As they die, dopamine production falls. When dopamine levels drop too low, the brain's movement control system breaks down—causing the tremors, stiffness, and slow movements that characterize Parkinson's disease.

How Levodopa Works (And Why It Eventually Fails)

The most common Parkinson's treatment—carbidopa/levodopa—works by giving the brain a raw material it can convert into dopamine. Think of it like delivering flour to a bakery: the bakery (surviving dopamine neurons) uses the flour (levodopa) to bake bread (dopamine).

This works well early in Parkinson's disease when there are still enough dopamine-producing neurons alive to do the conversion. But as the disease progresses and more neurons die, the "bakery" shrinks. There are fewer neurons to convert levodopa to dopamine, and the process becomes unreliable—leading to wearing off periods (when symptoms return before the next dose) and unpredictable on-off fluctuations.

How Apomorphine Works Differently: Direct Receptor Activation

Apomorphine bypasses the "bakery" entirely. Instead of providing a raw material for the brain to convert, apomorphine directly activates dopamine receptors on the target neurons. It is a dopamine agonist—a molecule that fits into dopamine receptor sites like a key fits a lock and turns on the same cellular machinery that real dopamine would activate.

Because apomorphine doesn't need to be converted by dying neurons, it works even in late-stage Parkinson's disease when levodopa has become unreliable. This is what makes it such a powerful rescue medication.

Which Dopamine Receptors Does Apomorphine Target?

The brain has five main types of dopamine receptors: D1, D2, D3, D4, and D5. Most dopamine agonists used in Parkinson's (like pramipexole or ropinirole) primarily target D2 and D3 receptors. Apomorphine is notably less selective—it activates D2, D3, D4, and D5 receptors, with high affinity for D4 and meaningful activation of D1 and D5 as well.

This broader receptor engagement is clinically significant. Research suggests that apomorphine's D1 receptor activity may contribute to its effectiveness and may also be associated with a lower rate of impulse control disorders compared to more D2/D3-selective agonists like pramipexole and ropinirole.

Why Apomorphine Works So Fast

Speed is apomorphine's defining characteristic. When injected subcutaneously (under the skin), apomorphine is absorbed directly into the bloodstream without passing through the digestive tract. It crosses the blood-brain barrier quickly and activates dopamine receptors within 10–20 minutes.

Oral medications like levodopa tablets must first be swallowed, absorbed from the gut (which can be slow and variable), transported to the liver (which partially breaks them down), and then delivered to the brain. This process typically takes 30–60 minutes—far too slow for an acute off episode. Apomorphine's subcutaneous delivery eliminates those bottlenecks.

Why Apomorphine Can't Be Taken by Mouth

Apomorphine undergoes extensive first-pass metabolism in the liver, meaning that when taken orally, the liver destroys most of the drug before it can reach the brain. This makes oral administration impractical. By injecting it subcutaneously, the drug bypasses the liver on the first pass and enters systemic circulation intact.

Why Apomorphine Also Causes Nausea

Apomorphine's mechanism of action also explains its most prominent side effect—severe nausea and vomiting. The brain has a "vomiting center" (chemoreceptor trigger zone) in an area called the area postrema, which sits outside the blood-brain barrier and is sensitive to dopamine receptor activation. When apomorphine activates dopamine receptors in this area, it stimulates the vomiting reflex—causing the nausea and vomiting that requires pre-treatment with trimethobenzamide.

To understand the full side effect profile of apomorphine, see our guide: Apomorphine side effects: what to expect and when to call your doctor.

If you're having trouble finding apomorphine at a pharmacy near you, medfinder can call pharmacies in your area to find which ones have it in stock.